FLUOROPHARMA MEDICAL, INC. company info

CIK 1402785
IRS Number 208325616
State of incorporation NV
Business address 8 HILLSIDE AVENUE
SUITE 207
MONTCLAIR
NJ
07042
Mail address 8 HILLSIDE AVENUE
SUITE 207
MONTCLAIR
NJ
07042

Short summary

FLUOROPHARMA MEDICAL, INC. is a New Jersey company, with head office located at 8 Hillside Avenue Montclair, New Jersey 07042. In 2016 the company owned a total of 334.76 thousand USD worth of assets, including 47.78 thousand USD worth of current assets. 2010 was the year when the company amassed the most assets.

FLUOROPHARMA MEDICAL, INC. Income Statement

Name [in Millions USD]200220032004200520062007200820092010201120122013201420152016Trends
Research and development 0.270.040.641.421.311.750.720.51
Operating Expenses 1.110.893.274.154.365.173.192.20
Operating Income (Loss) -3.19-2.20
Interest expense 0.060.050.110.050.100.871.26
Income Tax Expense (Benefit) 00
Net income -0.33-0.69-2.00-2.35-2.270.13-0.95-3.26-5.61-5.61-4.13-3.16-2.05

FLUOROPHARMA MEDICAL, INC. Balance Sheet

Name [in Millions USD]200220032004200520062007200820092010201120122013201420152016Trends
Cash and cash equivalents 0.003.021.690.070.100.040.410.02
Available-for-sale Securities, Current 0.63
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.13-0.14-0.16-0.170.180.18
Total assets 0.193.392.050.320.670.520.770.33
Current assets 0.063.331.800.100.260.170.460.05
Accounts payable 0.790.540.230.340.771.671.401.41
Total current liabilities 1.250.620.230.574.507.4210.9610.51
Common Stock, Value, Issued 0.010.020.020.020.030.030.030.03
Retained Earnings (Accumulated Deficit) -7.51-10.62-14.62-24.17-27.68-31.16-35.18-35.18

FLUOROPHARMA MEDICAL, INC. Cash Flow

Name [in Millions USD]200220032004200520062007200820092010201120122013201420152016Trends
Net income -0.33-0.69-2.00-2.35-2.270.13-0.95-3.26-5.61-5.61-4.13-3.16-2.05
Depreciation and amortization 0.040.040.020.020.040.050.04
Depreciation 0.030.030.020.02
Amortization of Intangible Assets 0.020.010.010.030.040.04
Accounts receivable 0.05
Accounts payable -0.100.06-0.32-0.060.050.910.620.32
Deferred revenue 00.41
Net Cash Provided by (Used in) Operating Activities -0.68-0.48-2.28-3.28-3.33-3.32-2.68-0.88
Payments to Acquire Property, Plant, and Equipment 0.000.000.160.04-0.01-0.010.010.00
Payments to Acquire Intangible Assets 0.35
Net Cash Provided by (Used in) Investing Activities -0.00-0.00-0.19-0.041.80-0.210.03-0.00
Net Cash Provided by (Used in) Financing Activities 0.690.495.721.361.372.222.690.62
Cash and Cash Equivalents, Period Increase (Decrease) 0.000.013.25-1.96-0.16-0.890.04-0.27